Metraipolis › archive › dc_a1fc7b35971c

Xuebijing injection in the treatment of COVID-19: An update on clinical studies, potentially active metabolites and mechanisms — Europe PMC PMID:41614075

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41614075
DOI
10.3389/fphar.2025.1667022
License (as archived)
solo-consultazione
Archived
2026-11-06T19:58:48.262Z
SHA-256 of the archived text
9943ce173250811dbe2bd9f552fea340ae9a476a41b49d634a2b45deeadb6043
Stable URL of this page
https://metraipolis.com/documento/dc_a1fc7b35971c

How to cite

Xuebijing injection in the treatment of COVID-19: An update on clinical studies, potentially active metabolites and mechanisms — Europe PMC PMID:41614075 — Europe PMC (en), https://europepmc.org/article/MED/41614075 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a1fc7b35971c (Metraipolis archive dc_a1fc7b35971c, sha256 9943ce173250811dbe2bd9f552fea340ae9a476a41b49d634a2b45deeadb6043)
BibTeX
@misc{dca1fc7b35971c,
  title = {Xuebijing injection in the treatment of COVID-19: An update on clinical studies, potentially active metabolites and mechanisms — Europe PMC PMID:41614075},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41614075},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a1fc7b35971c; sha256 9943ce173250811dbe2bd9f552fea340ae9a476a41b49d634a2b45deeadb6043},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41614075. Agents can read the archived copy with the MCP tool read_document.